![Christopher Rivera](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Rivera
Directeur/Membre du Conseil chez
HAPBEE TECHNOLOGIES, INC.
Fortune : 21 375 $ au 31/08/2026
Profil
Christopher Eugene Rivera was the founder of Hyperion Therapeutics, Inc., founded in 2006, where the title held was Chief Executive Officer from 2006 to 2015.
Current jobs include Chairman, President & Chief Executive Officer at EMulate Therapeutics, Inc. since 2016; Director at Otonexus Medical Technologies, Inc. since 2023; Director at Hapbee Technologies, Inc. since 2022; and Director at CV6 Therapeutics (NI) Ltd. since 2018.
Former jobs include President & Chief Executive Officer at Life Science Washington, Principal at Centocor, Inc., Principal at Cephalon LLC, and Senior Vice President-Commercial Operations at Tercica, Inc. from 2005 to 2006.
Education includes undergraduate studies at Northwestern Oklahoma State University and graduate studies at the University of Oklahoma.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/08/2025 | 562 500 ( 0,24 % ) | 21 375 $ | 31/08/2026 |
Postes actifs de Christopher Rivera
| Sociétés | Poste | Début |
|---|---|---|
| HAPBEE TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 16/02/2022 |
EMulate Therapeutics, Inc.
 EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage health technology company which develops non-invasive therapies for cancers and neuropsychiatric conditions | Directeur Général | 01/01/2016 |
CV6 Therapeutics (NI) Ltd.
 CV6 Therapeutics (NI) Ltd. Pharmaceuticals: MajorHealth Technology Develop and manufactures pharmaceutical drugs | Directeur/Membre du Conseil | 01/01/2018 |
Otonexus Medical Technologies, Inc.
 Otonexus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Designs and develops ultrasound medical device that diagnoses middle ear infections in children and adults | Directeur/Membre du Conseil | 05/04/2023 |
Anciens postes connus de Christopher Rivera
| Sociétés | Poste | Fin |
|---|---|---|
| HYPERION THERAPEUTICS INC | Directeur Général | 01/01/2015 |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Directeur des opérations | 01/08/2006 |
Washington Biotechnology & Biomedical Association
 Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Directeur Général | - |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Corporate Officer/Principal | - |
Formation de Christopher Rivera
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage health technology company which develops non-invasive therapies for cancers and neuropsychiatric conditions | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Otonexus Medical Technologies, Inc.
Otonexus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Designs and develops ultrasound medical device that diagnoses middle ear infections in children and adults | Health Technology |
Northwestern Oklahoma State University
 Northwestern Oklahoma State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oklahoma
 University of Oklahoma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Hapbee Technologies, Inc.
 Hapbee Technologies, Inc. Electronic Production EquipmentElectronic Technology Develops and commercializes wearable wellness platform and products that enhance the human experience through magnetic field technology | Electronic Technology |
CV6 Therapeutics (NI) Ltd.
CV6 Therapeutics (NI) Ltd. Pharmaceuticals: MajorHealth Technology Develop and manufactures pharmaceutical drugs | Health Technology |
